Caitlin E Willard, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Professional Dr, Scarborough, ME 04074 Phone: 207-883-7926 Fax: 207-874-2466 |
Nicole Cherbuliez, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 96 Campus Dr, Suite 2c, Scarborough, ME 04074 Phone: 207-883-7926 Fax: 207-883-1925 |
Bryan Andrew Lamoreau, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Professional Dr, Scarborough, ME 04074 Phone: 207-883-7926 |
Dr. Smita Sonti, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 153 Us Route 1, Scarborough, ME 04074 Phone: 207-799-8596 Fax: 207-799-1730 |
News Archive
New research suggests that just one or two individual herpes virus particles attack a skin cell in the first stage of an outbreak, resulting in a bottleneck in which the infection may be vulnerable to medical treatment.
KemPharm, Inc., a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular entity (NME) prodrugs, announced today that it received a No Objection Letter (NOL) from Health Canada to begin clinical trials in Canada for its lead product candidate KP201 (benzhydrocodone hydrochloride and acetaminophen)
Writing in the Department of State's "DipNote" blog, Kris Balderston, special representative for the Secretary of State's Global Partnerships Initiative, and Jacob Moss, U.S. coordinator for the Global Alliance for Clean Cookstoves, highlight the Global Burden of Disease Study 2010 published last week in the Lancet, "which estimates that household air pollution attributed to cooking over open fires or basic cookstoves causes the premature deaths of approximately four million people annually - many of them women and young children."
A recent study demonstrated that two commercially available surface disinfectant formulations and one hand disinfection formulation that claim "virucidal activity against enveloped viruses" are effective in inactivating the SARS-CoV-2 virus. Their study has been published on the preprint server bioRxiv.
A study by Mayo Clinic researchers published in Kidney International Reports finds that immune checkpoint inhibitors, may have negative consequences in some patients, including acute kidney inflammation, known as interstitial nephritis. Immune checkpoint inhibitors are used to treat cancer by stimulating the immune system to attack cancerous cells.
› Verified 4 days ago